comparative effectiveness

Commercial payers are spending almost twice as much on chemotherapy administered in hospital outpatient departments compared with therapy administered in physician offices.
Researchers compared the overall survival, cancer-specific survival, and associated costs of trimodal therapy versus radical cystectomy for patients with localized muscle-invasive bladder cancer.
In a recent study, researchers evaluated the role of autologous stem cell transplantation in patients with multiple myeloma in the context of novel agents.
A recent study compared the effects of the standard of care alone versus combining the standard treatment with a TKI for patients with recurrent epithelial ovarian cancer.
A recent study compared a targeted therapy with standard chemotherapy for treatment-naïve ALK-positive advanced non-small cell lung cancer.
A comparative effectiveness study analyzed usual care versus multilevel, multicomponent implementation strategies for blood pressure control in patients with hypertension.
A recent study compared the effects of laser-assisted resection with pulmonary metastasectomy in patients with extrathoracic sarcoma.
A single-agent therapy is an effective chemotherapy-free option for patients with marginal zone lymphoma previously exposed to conventional monotherapy.
A monotherapy produced better overall survival outcomes when compared with a standard combination regimen in patients with heavily pretreated multiple myeloma, according to a recent study.